492 related articles for article (PubMed ID: 1328365)
1. Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids.
Fagerberg B; Berglund A; Andersson OK; Berglund G
J Hypertens; 1992 Sep; 10(9):1053-61. PubMed ID: 1328365
[TBL] [Abstract][Full Text] [Related]
2. A health-economic comparison of diet and drug treatment in obese men with mild hypertension.
Johannesson M; Fagerberg B
J Hypertens; 1992 Sep; 10(9):1063-70. PubMed ID: 1328366
[TBL] [Abstract][Full Text] [Related]
3. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives.
Feldstein CA; Renauld A; Akopian M; Olivieri AO; Garrido D
J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552
[TBL] [Abstract][Full Text] [Related]
4. Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients.
Faria AN; Ribeiro Filho FF; Kohlmann NE; Gouvea Ferreira SR; Zanella MT
Diabetes Obes Metab; 2005 May; 7(3):246-53. PubMed ID: 15811141
[TBL] [Abstract][Full Text] [Related]
5. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
Lindholm LH; Persson M; Alaupovic P; Carlberg B; Svensson A; Samuelsson O
J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
[TBL] [Abstract][Full Text] [Related]
6. Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects.
de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O
Ann Nutr Metab; 2007; 51(2):134-8. PubMed ID: 17536190
[TBL] [Abstract][Full Text] [Related]
7. Effect of orlistat on cardiovascular disease risk in obese adults.
Swinburn BA; Carey D; Hills AP; Hooper M; Marks S; Proietto J; Strauss BJ; Sullivan D; Welborn TA; Caterson ID
Diabetes Obes Metab; 2005 May; 7(3):254-62. PubMed ID: 15811142
[TBL] [Abstract][Full Text] [Related]
8. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M; Richter WO; Schwandt P; Holzgreve H
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive effect of diet compared with drug treatment in obese men with mild hypertension.
Berglund A; Andersson OK; Berglund G; Fagerberg B
BMJ; 1989 Aug; 299(6697):480-5. PubMed ID: 2507028
[TBL] [Abstract][Full Text] [Related]
11. Weight loss improves heart rate recovery in overweight and obese men with features of the metabolic syndrome.
Brinkworth GD; Noakes M; Buckley JD; Clifton PM
Am Heart J; 2006 Oct; 152(4):693.e1-6. PubMed ID: 16996838
[TBL] [Abstract][Full Text] [Related]
12. Differences in glycaemic status do not predict weight loss in response to hypocaloric diets in obese patients.
de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R
Clin Nutr; 2006 Feb; 25(1):117-22. PubMed ID: 16278036
[TBL] [Abstract][Full Text] [Related]
13. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group.
Arch Intern Med; 1997 Mar; 157(6):657-67. PubMed ID: 9080920
[TBL] [Abstract][Full Text] [Related]
14. The effect of 1-yr sibutramine treatment on glucose tolerance, insulin sensitivity and serum lipid profiles in obese subjects.
Sabuncu T; Ucar E; Birden F; Yasar O
Diabetes Nutr Metab; 2004 Apr; 17(2):103-7. PubMed ID: 15244102
[TBL] [Abstract][Full Text] [Related]
15. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Romero E
Nutrition; 2008 Jun; 24(6):517-21. PubMed ID: 18343636
[TBL] [Abstract][Full Text] [Related]
16. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
[TBL] [Abstract][Full Text] [Related]
17. Weight loss in obese men by caloric restriction and high-dose diazoxide-mediated insulin suppression.
van Boekel G; Loves S; van Sorge A; Ruinemans-Koerts J; Rijnders T; de Boer H
Diabetes Obes Metab; 2008 Dec; 10(12):1195-203. PubMed ID: 18476985
[TBL] [Abstract][Full Text] [Related]
18. Substitution of high monounsaturated fatty acid avocado for mixed dietary fats during an energy-restricted diet: effects on weight loss, serum lipids, fibrinogen, and vascular function.
Pieterse Z; Jerling JC; Oosthuizen W; Kruger HS; Hanekom SM; Smuts CM; Schutte AE
Nutrition; 2005 Jan; 21(1):67-75. PubMed ID: 15661480
[TBL] [Abstract][Full Text] [Related]
19. Moxonidine improves insulin sensitivity in insulin-resistant hypertensives.
Haenni A; Lithell H
J Hypertens Suppl; 1999 Aug; 17(3):S29-35. PubMed ID: 10489096
[TBL] [Abstract][Full Text] [Related]
20. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
